focus -WSS

focus

author：hotspot 2025-08-23 04:59:12 - browse：24672

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Choosing scientific sides in the fight against Alzheimer's

WSS

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Cybersecurity threat forces Lurie Children's to take systems offline

ARCH Venture Partners is raising $3 billion for a life sciences fund

Lessons Learned: This is why you network to find that industry job you want

Biden praises World Series champion Astros for impact off the field during White House celebration

Cybersecurity threat forces Lurie Children's to take systems offline

hotspot

focus

Sign up for D.C. Diagnosis

explore

Moonlake's readout produced a cash windfall. Risks remain

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

ChatGPT in medicine: STAT answers readers' burning questions

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Moonlake's readout produced a cash windfall. Risks remain

Wegovy cuts risk of cardiovascular events by 20%, study finds

Novavax promises a turnaround & Lilly roils the obesity market

Even great ERs can’t make up for American health disparities

Drug repurposing or repositioning? The language matters

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

knowledge

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Sage's campaign to raise awareness of postpartum depression hits a nerve

The real point of Kenneth Smith’s execution by nitrogen gas

Novo Nordisk to expand supply of Wegovy for U.S. patients

Woodcock on FDA’s accelerated approval and her next chapter

Juul spent big to court Black leaders to promote its e

leisure time

focus

Wikipedia

leisure time